GNI Group (FRA:3G6) OCF Margin %: -7.51% (As of Mar. 2026)

What is GNI Group OCF Margin %?

GNI Group FRA:3G6 -0.75% 83 OCF Margin % is -7.51% as of Mar. 2026. GuruFocus rates FRA:3G6 with a GF Score™ of 83/100 and a GF Value™ of €14.61. The stock has 5 warning signs investors should review. Among 960 Biotechnology companies, GNI Group ranks better than 62.81% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. GNI Group's Cash Flow from Operations for the three months ended in Mar. 2026 was €-2.3 Mil. GNI Group's Revenue for the three months ended in Mar. 2026 was €30.1 Mil. Therefore, GNI Group's OCF Margin % for the quarter that ended in Mar. 2026 was -7.51%.

As of today, GNI Group's current OCF Yield % is -1.80%.

The historical rank and industry rank for GNI Group's OCF Margin % or its related term are showing as below:

FRA:3G6' s OCF Margin % Range Over the Past 10 Years
Min: -39.69 Med: 3.31 Max: 25.18
Current: -9.21

During the past 13 years, the highest OCF Margin % of GNI Group was 25.18%. The lowest was -39.69%. And the median was 3.31%.

FRA:3G6's OCF Margin % is ranked better than
62.81% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs FRA:3G6: -9.21

GNI Group OCF Margin % Related Terms

GNI Group OCF Margin % Historical Data

* Premium members only.

The historical data trend for GNI Group's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group OCF Margin % Chart

GNI Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

4.35

2.26

25.18

-13.40

-8.97

GNI Group Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-5.41	-9.29	3.16	-22.73	-7.51

FRA:3G6 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, GNI Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GNI Group OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's OCF Margin % distribution charts can be found below:

* The bar in red indicates where GNI Group's OCF Margin % falls into.

Save Embed

83GF Score

GNI Group Ltd FRA:3G6

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

GNI Group OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

GNI Group's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-13.189	/	147.012
	=	-8.97 %

GNI Group's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-2.262	/	30.123
	=	-7.51 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -7.51% mean?

GNI Group (FRA:3G6) has a OCF Margin % of -7.51% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GNI Group and its competitors. According to the industry distribution chart, GNI Group ranks #357 out of 960 companies in the Biotechnology industry, placing it in the top 37.2%.

Is GNI Group's OCF Margin % too high?

GNI Group's current OCF Margin % is -7.51%. Based on the distribution chart, GNI Group ranks #357 out of 960 companies in the Biotechnology industry, which is above the industry midpoint. Overall, GNI Group has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.

How does GNI Group's OCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, GNI Group ranks #357 out of 960 companies for OCF Margin %. This puts GNI Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GNI Group and its competitors. GNI Group's current OCF Margin % is -7.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is GNI Group stock overvalued right now?

GNI Group (FRA:3G6) has a current OCF Margin % of -7.51%. The stock's GF Value™ is €14.61, compared to a current price of €13.20 — trading 9.7% below its estimated fair value. The current OCF Margin % is -7.51%. GNI Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For GNI Group (FRA:3G6), the current OCF Margin % is -7.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GNI Group (FRA:3G6) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of €13.20 is trading 9.7% below its estimated GF Value™ of €14.61.

Key valuation signals for FRA:3G6:

OCF Margin %: -7.51%
GF Value™: €14.61 vs. price of €13.20 (9.7% below fair value)
GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the FRA:3G6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GNI Group Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:4587 TSE:4974 TSE:4592 TSE:4565 TSE:4588 TSE:4593 TSE:4894 TSE:219A TSE:504A TSE:7774 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 2160:Japan

Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023

Website https://www.gnipharma.com

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

83GF Score

Get the complete analysis for FRA:3G6

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.20

Price

€14.61

GF Value

View FRA:3G6 Analysis

See OCF Margin % data for all stocks →